Tempest Therapeutics IncNASDAQ:TPST
- LAST PRICE0.8691
- TODAY'S CHANGE (%)-0.1010 (-10.4113%)
- Bid / Lots0.8690/ 10
- Ask / Lots0.8692/ 2
- Open / Previous Close0.9600 / 0.9701
- Day Range
- 52 Week Range
- Volume2,892,533
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | TPST |
|---|---|---|
| 09:32 ET | 111648 | 0.93 |
| 09:33 ET | 307638 | 0.8895 |
| 09:35 ET | 23773 | 0.908 |
| 09:37 ET | 76498 | 0.8825 |
| 09:39 ET | 79581 | 0.8999 |
| 09:42 ET | 55937 | 0.8954 |
| 09:44 ET | 71814 | 0.9389 |
| 09:46 ET | 19303 | 0.894603 |
| 09:48 ET | 142637 | 0.8976 |
| 09:50 ET | 48157 | 0.8688 |
| 09:51 ET | 91919 | 0.8619 |
| 09:53 ET | 56747 | 0.87026 |
| 09:55 ET | 10920 | 0.863349 |
| 09:57 ET | 93107 | 0.8907 |
| 10:00 ET | 28337 | 0.860325 |
| 10:02 ET | 127150 | 0.8563 |
| 10:04 ET | 78461 | 0.8477 |
| 10:06 ET | 109036 | 0.859999 |
| 10:08 ET | 25713 | 0.865 |
| 10:09 ET | 18852 | 0.863867 |
| 10:11 ET | 14411 | 0.8638 |
| 10:13 ET | 11126 | 0.8782 |
| 10:15 ET | 31519 | 0.8799 |
| 10:18 ET | 36443 | 0.8639 |
| 10:20 ET | 20336 | 0.86699 |
| 10:22 ET | 39353 | 0.87684 |
| 10:24 ET | 32891 | 0.8718 |
| 10:26 ET | 8219 | 0.873 |
| 10:27 ET | 61117 | 0.8814 |
| 10:29 ET | 32395 | 0.8898 |
| 10:31 ET | 35400 | 0.9 |
| 10:33 ET | 65334 | 0.9154 |
| 10:36 ET | 51987 | 0.9044 |
| 10:38 ET | 36903 | 0.9024 |
| 10:40 ET | 13196 | 0.8976 |
| 10:42 ET | 9569 | 0.9049 |
| 10:44 ET | 22770 | 0.8987 |
| 10:45 ET | 3794 | 0.9099 |
| 10:47 ET | 10344 | 0.9075 |
| 10:49 ET | 8263 | 0.9028 |
| 10:51 ET | 16596 | 0.886 |
| 10:54 ET | 1600 | 0.8996 |
| 10:56 ET | 9594 | 0.8999 |
| 10:58 ET | 4500 | 0.8985 |
| 11:00 ET | 500 | 0.8973 |
| 11:02 ET | 3754 | 0.8974 |
| 11:03 ET | 900 | 0.8902 |
| 11:05 ET | 4440 | 0.885 |
| 11:07 ET | 370 | 0.8847 |
| 11:09 ET | 3906 | 0.8848 |
| 11:12 ET | 2104 | 0.8848 |
| 11:14 ET | 3900 | 0.8853 |
| 11:16 ET | 200 | 0.886 |
| 11:18 ET | 2865 | 0.8861 |
| 11:20 ET | 1400 | 0.88545 |
| 11:21 ET | 74164 | 0.8704 |
| 11:23 ET | 7200 | 0.8792 |
| 11:25 ET | 2400 | 0.8792 |
| 11:27 ET | 28830 | 0.8807 |
| 11:30 ET | 800 | 0.8807 |
| 11:32 ET | 10413 | 0.88689 |
| 11:34 ET | 2000 | 0.886 |
| 11:36 ET | 2544 | 0.8856 |
| 11:38 ET | 64113 | 0.8652 |
| 11:39 ET | 19334 | 0.8705 |
| 11:41 ET | 14015 | 0.8653 |
| 11:43 ET | 18554 | 0.8687 |
| 11:45 ET | 4399 | 0.87 |
| 11:48 ET | 4655 | 0.8848 |
| 11:50 ET | 4100 | 0.883 |
| 11:52 ET | 5520 | 0.88 |
| 11:54 ET | 10600 | 0.8787 |
| 11:56 ET | 1013 | 0.8767 |
| 11:57 ET | 4215 | 0.87115 |
| 11:59 ET | 2500 | 0.8725 |
| 12:01 ET | 6191 | 0.87 |
| 12:03 ET | 3801 | 0.8712 |
| 12:06 ET | 21600 | 0.875 |
| 12:08 ET | 200 | 0.8829 |
| 12:10 ET | 20231 | 0.8679 |
| 12:12 ET | 16990 | 0.8688 |
| 12:14 ET | 16200 | 0.8688 |
| 12:15 ET | 3400 | 0.868246 |
| 12:17 ET | 9500 | 0.8636 |
| 12:19 ET | 2400 | 0.863 |
| 12:21 ET | 1450 | 0.861501 |
| 12:24 ET | 300 | 0.863 |
| 12:26 ET | 1100 | 0.8604 |
| 12:28 ET | 2801 | 0.8604 |
| 12:30 ET | 21964 | 0.8659 |
| 12:32 ET | 884 | 0.8811 |
| 12:33 ET | 29887 | 0.8716 |
| 12:35 ET | 4851 | 0.8639 |
| 12:37 ET | 100 | 0.8639 |
| 12:39 ET | 7650 | 0.8626 |
| 12:42 ET | 900 | 0.868759 |
| 12:44 ET | 2242 | 0.863 |
| 12:46 ET | 4126 | 0.865949 |
| 12:48 ET | 14131 | 0.8645 |
| 12:50 ET | 300 | 0.8698 |
| 12:51 ET | 4902 | 0.862018 |
| 12:53 ET | 1700 | 0.862 |
| 12:55 ET | 4308 | 0.8621 |
| 12:57 ET | 11029 | 0.862 |
| 01:00 ET | 45304 | 0.8636 |
| 01:02 ET | 2688 | 0.865451 |
| 01:04 ET | 1520 | 0.868 |
| 01:06 ET | 779 | 0.8699 |
| 01:08 ET | 1518 | 0.87 |
| 01:09 ET | 1750 | 0.8686 |
| 01:11 ET | 1603 | 0.8699 |
| 01:13 ET | 1410 | 0.8699 |
| 01:15 ET | 2800 | 0.8655 |
| 01:18 ET | 216 | 0.862 |
| 01:20 ET | 100 | 0.868 |
| 01:22 ET | 200 | 0.862 |
| 01:24 ET | 1805 | 0.8679 |
| 01:26 ET | 3168 | 0.8638 |
| 01:27 ET | 3946 | 0.8639 |
| 01:29 ET | 10248 | 0.86585 |
| 01:31 ET | 16548 | 0.8697 |
| 01:33 ET | 169 | 0.8698 |
| 01:36 ET | 250 | 0.8699 |
| 01:38 ET | 1690 | 0.87 |
| 01:40 ET | 395 | 0.87 |
| 01:42 ET | 885 | 0.8697 |
| 01:44 ET | 3917 | 0.8697 |
| 01:45 ET | 700 | 0.869435 |
| 01:47 ET | 1170 | 0.869 |
| 01:49 ET | 7661 | 0.8692 |
| 01:54 ET | 200 | 0.8693 |
| 01:56 ET | 4092 | 0.8693 |
| 01:58 ET | 300 | 0.8692 |
| 02:00 ET | 13200 | 0.8691 |
| 02:02 ET | 261 | 0.8692 |
| 02:03 ET | 300 | 0.8691 |
Nov 13, 2024
DJ Tempest Therapeutics Is Maintained at Overweight by Piper Sandler, from 12:00PM ET on Wednesday Nov 13, 2024 by Dow Jones
12:00PM ET on Wednesday Nov 13, 2024 by Dow JonesDJ Tempest Therapeutics Price Target Maintained With a $47.00/Share by HC Wainwright & Co., from 7:35AM ET on Wednesday Nov 13, 2024 by Dow Jones
7:35AM ET on Wednesday Nov 13, 2024 by Dow Jones
Nov 12, 2024
Tempest Reports Third Quarter 2024 Financial Results and Provides Business Update, from 4:21PM ET on Tuesday Nov 12, 2024 by Dow Jones
4:21PM ET on Tuesday Nov 12, 2024 by Dow JonesPress Release: Tempest Reports Third Quarter 2024 Financial Results and Provides Business Update, from 4:21PM ET on Tuesday Nov 12, 2024 by Dow Jones
4:21PM ET on Tuesday Nov 12, 2024 by Dow JonesTempest Receives FDA Study May Proceed for Pivotal Phase 3 Trial of Amezalpat Combination Therapy for the Treatment of First-Line Hepatocellular Carcinoma, from 8:00AM ET on Tuesday Nov 12, 2024 by Dow Jones
8:00AM ET on Tuesday Nov 12, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Tempest Therapeutics Inc | 24.5M | -0.6x | --- |
GeoVax Labs Inc | 24.6M | -0.2x | --- |
Cell Source Inc | 24.7M | -4.0x | --- |
Aeon Biopharma Inc | 24.2M | -0.1x | --- |
Ocean Biomedical Inc | 24.9M | -0.2x | --- |
Neurosense Therapeutics Ltd | 25.3M | -2.8x | --- |
Company Information
Tempest Therapeutics, Inc. is a clinical-stage biotechnology company advancing a diverse portfolio of small molecule product candidates containing tumor-targeted and/or immune-mediated mechanisms with the potential to treat a range of tumors. Its two clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495. TPST-1120 is a selective antagonist of peroxisome proliferator-activated receptor alpha (PPAR). The ongoing global randomized Phase Ib/II trial of TPST-1120 combined with the standard-of-care first-line regimen of atezolizumab and bevacizumab in patients with advanced or metastatic hepatocellular carcinoma (HCC). The Company’s second clinical program, TPST-1495, a dual antagonist of the EP2 and EP4 receptors of prostaglandin E2, is in an ongoing Phase I combination trial in patients with endometrial cancer.
Contact Information
- Headquarters
- 2000 SIERRA POINT PARKWAY, SUITE 400BRISBANE, CA, United States 94005
- Phone
- 415-798-8589
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- Michael Raab
- President, Chief Executive Officer, Director
- Stephen Brady
- Executive Vice President, Chief Medical Officer
- Samuel Whiting
- Vice President - Strategy and Finance, Corporate Secretary
- Nicholas Maestas
- Vice President - Regulatory Affairs
- Sheldon Mullins
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $24.5M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 25.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | -1.76 |
EPS | $-1.57 |
Book Value | $1.21 |
P/E Ratio | -0.6x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
